Clinical response to methylphenidate in children diagnosed with attention-deficit hyperactivity disorder and comorbid psychiatric disorders

Canadian Journal of Psychiatry

Volumn 55, Issue 5, 2010, Pages 305-312

  Ter Stepanian, Mariam ^a   Grizenko, Natalie ^a,b   Zappitelli, Michael ^c   Joober, Ridha ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^c MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

Anxiety; Attention deficit hyperactivity disorder; Comorbidity; Conduct disorder; Methylphenidate; Oppositional defiant disorder

Indexed keywords

METHYLPHENIDATE; PLACEBO;

ACADEMIC ACHIEVEMENT; AGE DISTRIBUTION; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CHILD BEHAVIOR; CLINICAL TRIAL; COMORBIDITY; CONDUCT DISORDER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; DYSTHYMIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; MENTAL PERFORMANCE; MORNING DOSAGE; OPPOSITIONAL DEFIANT DISORDER; PHOBIA; PRESCHOOL CHILD; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHOOL CHILD; SEPARATION ANXIETY; SEX DIFFERENCE; SOCIAL PHOBIA; SOCIAL STATUS;

EID: 77952916177     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674371005500506     Document Type: Article

References (40)

1. Scahill L, Schwab-Stone M. Epidemiology of ADHD in school-age children. Child Adolesc Psychiatr Clin N Am. 2000;9:541-555, vii.
2. Pliszka SR. Patterns of psychiatric comorbidity with attention-deficit/ hyperactivity disorder. Child Adolesc Psychiatr Clin N Am. 2000;9:525-540, vii.
3. Pliszka SR. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview. J Clin Psychiatry. 1998;59(Suppl 7):50-58. (Pubitemid 28317222)
4. Robison LM, Sclar DA, Skaer TL. Attention-deficit-hyperactivity disorder. N Engl J Med. 1999;340:1767.
5. Connor DF, Edwards G, Fletcher KE, et al. Correlates of comorbid psychopathology in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2003;42:193-200. (Pubitemid 39610599)
6. Robison LM, Sclar DA, Skaer TL, et al. National trends in the prevalence of attention-deficit/hyperactivity disorder and the prescribing of methylphenidate among school-age children: 1990-1995. Clin Pediatr. 1999;38:209-217.
7. Jensen PS. Introduction - ADHD comorbidity and treatment outcomes in the MTA. J Am Acad Child Adolesc Psychiatry. 2001;40:134-136. (Pubitemid 32111016)
8. Jensen PS, Hinshaw SP, Kraemer HC, et al. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry. 2001;40:147-158.
9. Waxmonsky J. Assessment and treatment of attention deficit hyperactivity disorder in children with comorbid psychiatric illness. Curr Opin Pediatr. 2003;15:476-482. (Pubitemid 37204804)
10. Ghuman JK, Riddle MA, Vitiello B, et al. Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharmacol. 2007;17:563-580. (Pubitemid 350058980)
11. Boles M, Lynch FL, DeBar LL. Variations in pharmacotherapy for attention deficit hyperactivity disorder in managed care. J Child Adolesc Psychopharmacol. 2001;11:43-52. (Pubitemid 32295182)
12. Pliszka SR. Effect of anxiety on cognition, behavior, and stimulant response in ADHD. J Am Acad Child Adolesc Psychiatry. 1989;28:882-887.
13. Diamond IR, Tannock R, Schachar RJ. Response to methylphenidate in children with ADHD and comorbid anxiety. J Am Acad Child Adolesc Psychiatry. 1999;38:402-409. (Pubitemid 29153111)
14. van der Oord S, Prins PJ, Oosterlaan J, et al. Treatment of attention deficit hyperactivity disorder in children. Predictors of treatment outcome. Eur Child Adolesc Psychiatry. 2008;17:73-81.
15. Goez H, Back-Bennet O, Zelnik N. Differential stimulant response on attention in children with comorbid anxiety and oppositional defiant disorder. J Child Neurol. 2007;22:538-542. (Pubitemid 46951495)
16. MTA Cooperative Group. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999;56:1088-1096.
17. Wechsler D. Wechsler Intelligence Scale for Children. San Antonio (TX): Psychological Corporation; 1991.
18. Shaffer D, Fisher P, Lucas CP, et al. NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses. J Am Acad Child Adolesc Psychiatry. 2000;39:28-38. (Pubitemid 30029897)
19. Conners CK, Epstein JN, Angold A, et al. Continuous performance test performance in a normative epidemiological sample. J Abnorm Child Psychol. 2003;31:555-562. (Pubitemid 37229133)
20. Barkley RA. Tests and observational measures. In: Barkley RA, editor. Attention deficit hyperactivity disorder: a handbook for diagnosis and treatment. New York (NY): Guilford Press; 1990. p 327-353.
21. Karama S, Amor LB, Grizenko N, et al. Factor structure of the Restricted Academic Situation Scale: implications for ADHD. J Atten Disord. 2009;12:442-448.
22. Conners CK. Conners Rating Scales (revised), technical manual. Toronto (ON): Toronto Multi-Health Systems Inc; 1997.
23. Grizenko N, Bhat M, Schwartz G, et al. Efficacy of methylphenidate in children with attention-deficit hyperactivity disorder and learning disabilities: a randomized crossover trial. J Psychiatry Neurosci. 2006;31:46-51. (Pubitemid 43305310)
24. Grizenko N, Kovacina B, Amor LB, et al. Relationship between response to methylphenidate treatment in children with ADHD and psychopathology in their families. J Am Acad Child Adolesc Psychiatry. 2006;45:47-53. (Pubitemid 41818140)
25. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC): APA; 1994.
26. Costello J, Erkanli A, Angold A. Is there an epidemic of child or adolescent depression? J Child Psychol Psychiatry. 2006;47:1263-1271.
27. Willcutt EG, Pennington BF, Chhabildas NA, et al. Psychiatric comorbidity associated with DSM-IV ADHD in a nonreferred sample of twins. J Am Acad Child Adolesc Psychiatry. 1999;38:1355-1362.
28. Powe TJ, Costing TE, Eiraldi RB, et al. Variations in anxiety and depression as a function of ADHD subtypes defined by DSM-IV: do subtype differences exist or not? J Abnorm Child Psychol. 2004;32:27-37.
29. Newcorn JH, Halperin JM, Jensen PS, et al. Symptom profiles in children with ADHD: effects of comorbidity and gender. J Am Acad Child Adolesc Psychiatry. 2001;40:137-146.
30. Spencer T, Biederman J, Wilens T, et al. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry. 1996;35:409-432. (Pubitemid 126418605)
31. Serra-Pinheiro MA, Mattos P, Souza I, et al. The effect of methylphenidate on oppositional defiant disorder comorbid with attention deficit/hyperactivity disorder. Arq Neuropsiquiatr. 2004;62:399-402. (Pubitemid 38923841)
32. Gadow KD, Nolan EE, Sverd J, et al. Methylphenidate in children with oppositional defiant disorder and both comorbid chronic multiple tic disorder and ADHD. J Child Neurol. 2008;23(9):981-990.
33. Lynch FL, Clarke GN. Estimating the economic burden of depression in children and adolescents. Am J Prev Med. 2006;31:S143-S151.
34. Abikoff H, McGough J, Vitiello B, et al. Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders. J Am Acad Child Adolesc Psychiatry. 2005;44:418-427. (Pubitemid 40559689)
35. Gadow KD, Nolan EE, Sverd J, et al. Anxiety and depression symptoms and response to methylphenidate in children with attention-deficit hyperactivity disorder and tic disorder. J Clin Psychopharmacol. 2002;22:267-274. (Pubitemid 34546842)
36. March JS, Swanson JM, Arnold LE, et al. Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA). J Abnorm Child Psychol. 2000;28:527-541.
37. Brownell MD, Mayer T, Chateau D. The incidence of methylphenidate use by Canadian children: what is the impact of socioeconomic status and urban or rural residence? Can J Psychiatry. 2006;51:847-854.
38. Ollendick TH, Jarrett MA, Grills-Taquechel AE, et al. Comorbidity as a predictor and moderator of treatment outcome in youth with anxiety, affective, attention deficit/hyperactivity disorder, and oppositional/conduct disorders. Clin Psychol Rev. 2008;28:1447-1471.
39. Canadian Attention-Deficit Hyperactivity Disorder Resource Alliance (CADDRA). Canadian ADHD practice guidelines. Toronto (ON): CADDRA; 2008.
40. Biederman J, Spencer T, Wilens T. Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder. Int J Neuropsychopharmacol. 2004;7:77-97. (Pubitemid 38523811)